Rchr
J-GLOBAL ID：201201000698413747   Update date: Aug. 26, 2024

Shinkai Masaharu

シンカイ マサハル | Shinkai Masaharu
Affiliation and department：
東京品川病院 治験開発・研究センター

About 東京品川病院 治験開発・研究センター


Job title： 副院長
Homepage URL  (1)： http://ycu-dp.umin.jp/index.html
Research field  (1)： Respiratory medicine
Research keywords  (3)： 臨床薬効学 ,  気道上皮における免疫調整作用 ,  気道分泌制御
Research theme for competitive and other funds  (2)：
  • 2016 - 2019 Development of novel biomarkers for the risk of COPD and prognosis
  • 2015 - 2017 喘息・COPDオーバーラップ症候群(ACOS)における気道分泌制御の重点的研究
Papers (130)：
  • Masahiro Shinoda, Shinichiro Ota, Yuto Yoshida, Takatomo Hirouchi, Kanako Shinada, Takashi Sato, Miwa Morikawa, Naoki Ishii, Masaharu Shinkai. High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case-Control Study. International Journal of General Medicine. 2023. Volume 16. 2337-2348
  • Tomohiro Takano, Takashi Sato, Ryutaro Kotaki, Saya Moriyama, Shuetsu Fukushi, Masahiro Shinoda, Kiyomi Kabasawa, Nagashige Shimada, Mio Kousaka, Yu Adachi, et al. Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain. Nature communications. 2023. 14. 1. 1451-1451
  • Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi, Sousuke Kubo, Katsushi Tanaka, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masanori Nishikawa, Kenji Miura, et al. Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study. BMC cancer. 2022. 22. 1. 1035-1035
  • Masaharu Shinkai, Takuhiro Sonoyama, Akari Kamitani, Risa Yokokawa Shibata, Naomi M. Seki, Shinya Omoto, Masahiro Shinoda, Takashi Sato, Naoki Ishii, Kenji Igarashi, et al. Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study. Vaccine. 2022
  • Kanako Shinada, Takashi Sato, Saya Moriyama, Yu Adachi, Masahiro Shinoda, Shinichiro Ota, Miwa Morikawa, Masamichi Mineshita, Takayuki Matsumura, Yoshimasa Takahashi, et al. Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir. Viruses. 2022. 14. 4. 670-670
ｍore...
MISC (33)：
ｍore...
Books (4)：
  • 生涯教育のためのセルフトレーニング問題と解説第3集「感染症」
    2015
  • 一発診断!一目瞭然!「特徴的な胸水から考えられる疾患は何か」
    2015
  • がん化学療法クリティカルポイント対応マニュアル「薬剤性肺障害(間質性肺炎など)予防、診断、管理」
    2013
  • 病理診断プラクティス 肺癌
    2011
Professional career (1)：
  • 医学博士 (横浜市立大学)
Work history (2)：
  • 2018/04 - 現在 Tokyo Shinagawa Hospital
  • 2016/04 - 2018/03 Yokohama City University Medical Center, Respiratory Disease Center, YCU Medical Center Department of Pulmonology Assistant Professor
Committee career (3)：
  • 2014/02 - 2020/03 日本呼吸器学会 代議員
  • 2017/02 - 2019/01 日本アレルギー学会 代議員
  • 2015/03 - 2018/03 神奈川県 指定難病事前審査員
Association Membership(s) (5)：
THE JAPAN LUNG CANCER SOCIETY ,  JAPANESE SOCIETY OF ALLERGOLOGY ,  THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPANESE RESPIRATORY SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM